goserelin
Showing 1 - 25 of 75
Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,
Recruiting
- Premenopausal Breast Cancer
- +2 more
- Goserelin
- +3 more
-
Taipei City, TaiwanDepartment of Oncology, National Taiwan University Hospital
Feb 7, 2023
Premature Ovarian Failure Trial in Fayoum (Goserelin, Chemotherapy)
Enrolling by invitation
- Premature Ovarian Failure
- Goserelin
- Chemotherapy
-
Fayoum, Mesala, EgyptBeni Suef university
Dec 8, 2022
Breast Cancer Trial in Worldwide (Docetaxel / Capecitabine, Capecitabine / Vinorelbine, Paclitaxel / Gemcitabine)
Active, not recruiting
- Breast Cancer
- Docetaxel / Capecitabine
- +5 more
-
Cairo, Egypt
- +51 more
Oct 24, 2022
Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer Trial in Hong Kong, Japan, Singapore (LEE011, Letrozole,
Completed
- Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
- LEE011
- +4 more
-
Hong Kong, Hong Kong
- +14 more
Oct 25, 2022
Breast Cancer. Real Clinical Practice in Russia
Recruiting
- Breast Cancer
- Neoadjuvant Endocrine Therapy
- Tamoxifen 20mg
- +4 more
-
Moscow, Russian FederationBlokhin's Russian Cancer Research Center
Apr 5, 2023
Breast Cancer, Breast Cancer - Female, Breast Cancer - Male Trial in Tampa (Tamoxifen, Ribociclib, Goserelin)
Completed
- Breast Cancer
- +2 more
- Tamoxifen
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 13, 2022
Metastatic Prostate Cancer in Pirkanmaa Hospital District in
Not yet recruiting
- Metastatic Castration Sensitive Prostate Cancer (mCSPC)
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- abiraterone
- +10 more
- (no location specified)
Jan 17, 2023
Breast Tumors Trial in Mönchengladbach (drug, diagnostic test, procedure)
Active, not recruiting
- Breast Neoplasms
- Perjeta Injectable Product
- +13 more
-
Mönchengladbach, GermanyEvangelisches Krankenhaus Bethesda Mönchengladbach
Oct 4, 2022
Breast Tumor, Breast Cancer, Hormone Receptor Positive Tumor Trial in Shanghai (PIK3CA inhibitor, AKT inhibitor, Carrelizumab)
Recruiting
- Breast Neoplasm
- +4 more
- PIK3CA inhibitor
- +12 more
-
Shanghai, Shanghai, ChinaBreast cancer institute of Fudan University Cancer Hospital
Jan 2, 2023
Metastatic Breast Cancer Trial in Chuo-ku, Nihonbashi, Koami-cho (Paclitaxel, Bevacizumab, Letrozole)
Completed
- Metastatic Breast Cancer
- Paclitaxel
- +7 more
-
Chuo-ku, Nihonbashi, Koami-cho, Tokyo, JapanJapan Breast Cancer Research Group
Aug 2, 2022
Breast Tumors Trial in Worldwide (Palbociclib, Placebo, Tamoxifen)
Active, not recruiting
- Breast Neoplasms
- Palbociclib
- +3 more
-
Nagoya, Aichi, Japan
- +22 more
Apr 4, 2022
Breast Cancer, Breast Carcinoma, Cancer of Breast Trial in Saint Louis, Lincoln (Palbociclib, Letrozole, Fulvestrant)
Active, not recruiting
- Breast Cancer
- +3 more
- Palbociclib
- +7 more
-
Saint Louis, Missouri
- +1 more
Jul 20, 2022
Breast Cancer Trial in Budapest (Tamoxifen, Goserelin, Letrozole 2.5Mg Tab)
Not yet recruiting
- Breast Cancer
- Tamoxifen
- +9 more
-
Budapest, HungaryNational Institute of Oncolgy
Nov 20, 2021
Breast Tumor, Breast Cancer, Breast Tumors Trial in Shanghai (Dalpiciclib, Pyrotinib, SHR-A1811)
Not yet recruiting
- Breast Neoplasm
- +9 more
- Dalpiciclib
- +15 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center Shanghai, China, 200032
Oct 13, 2022
Invasive Lobular Breast Carcinoma, ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Belgium, France (Entrectinib,
Recruiting
- Invasive Lobular Breast Carcinoma
- +2 more
- Entrectinib
- +2 more
-
Brussels, Belgium
- +9 more
May 4, 2022
Prostate Cancer Trial in Sao Paulo (Goserelin, Prednisone, Abiraterone)
Unknown status
- Prostate Cancer
- Goserelin
- +3 more
-
Sao Paulo, SP, BrazilInstituto do Cancer do Estado de Sao Paulo
May 14, 2021
Metastatic Breast Cancer Trial in Johannesburg (Palbociclib, Exemestane, Goserelin)
Recruiting
- Metastatic Breast Cancer
- Palbociclib
- +2 more
-
Johannesburg, South AfricaWits Oncology center
Jul 22, 2021